Abstract:Background: Cancer as the most malignant disease still demands the more effective therapeutics methods although continuous efforts have been input to cancer therapies. Recent studies indicate that only a small subset of cancer cells termed cancer stem cells (CSCs) contributes to tumor progression, metastasis and drug-resistance. Drugs targeting to CSCs might become more effective approaches to cancer therapy. To date, isolation and characterization of CSCs have largely depended on surface markers which are not specific or well-recognized for individual tumor types. Our goal is to develop methods for isolating and characterizing a set of lung CSCs based on the specific binding peptides for CSCs without any recognized definitive specific surface markers. Materials and Methods: Stem-like cells were enriched from non-small cell lung cancer (NSCLC) cell line H460 by sphere-forming assay. Characterized these stem-like cells by colony-forming assay, drug-resistance assay and soft agar assay. Screening and identification of specific binding peptides for CSCs were performed with bacteria surface display methods. The affinity between the specific binding peptides and CSCs was determined with fluorescence microscope and flow cytometric analysis. The specificity of peptides binding with CSCs was examined through comparing the binding capacity of peptides with either H460 cells or other cell lines including stem cells. The isolation of CSCs was performed using specific fluorescent peptides with FACS machine. The further characterization of selected CSCs including exploring the source and tumorigenesis mechanism of CSCs was performed through miRNA analysis. Results: Stem-like cells divided and formed tumor spheres in a couple of weeks, while most of cancer cells died in the serum-free medium. These stem-like cells were able to grow indefinitely as tumor spheres in long-term culture (more than 20 passages). Meanwhile, sphere cells could form colonies in the soft agar plates and exhibit the drug resistance capacity, which indicated that these sphere cells behaved as CSCs. Three peptides binding specifically to those CSCs were identified with bacteria surface display method. They could seldom bind with other cell types including H460 cells, H1299 sphere cells, HLF cells, MSCs and ESCs. One selected peptides named HCBP-1 exhibited highly specific binding capacity to H460 CSCs. The apparent dissociation constant (KD) was 6.4 × 10-7 M with a flow cytometry-based assay. In the peptides binding subgroup of H460 cells, at least 10 miRNAs presented the different expression rate from the H460 cells. Conclusions: In our study, a panel of specific binding peptides was identified with bacteria surface display method which could be used for isolation and characterization of CSCs without definitive CSCs markers. Furthermore, this new method could be potentially expanded to characterize and isolate CSCs in any types of cancer. Citation Information: Mol Cancer Ther 2013;12(11 Suppl):A54. Citation Format: Yimin Zhu, Anxin Wang. Isolation and characterization of cancer stem cells with peptides. [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2013 Oct 19-23; Boston, MA. Philadelphia (PA): AACR; Mol Cancer Ther 2013;12(11 Suppl):Abstract nr A54.

Identification of stem-like cells in non-small cell lung cancer cells with specific peptides.

Abstract A54: Isolation and Characterization of Cancer Stem Cells with Peptides.

Biomarkers Of Head And Neck Cancer Stem Cells And Targeted Therapeutic Strategies

Wnt/β-catenin Signaling Pathway in Lung Cancer Stem Cells is a Potential Target for the Development of Novel Anticancer Drugs.

Identification and characterization of side population cells in human lung adenocarcinoma SPC-A1 cells

Identification and Characterization of CD133(pos) Subpopulation Cells from a Human Laryngeal Cancer Cell Line.

Cooperation of Side Population Cells with CD133 to Enrich Cancer Stem Cells in a Laryngeal Cancer Cell Line

Identification of a cancer stem-like population in the Lewis lung cancer cell line.

Lung Cancer-Targeting Peptides with Multi-subtype Indication for Combinational Drug Delivery and Molecular Imaging

[Isolation and in Vitro Characterization of CD133(+) Side Population Cells from Laryngeal Cancer Cell Line].

[Screening and Identification of the Peptides Specifically Binding to Human Non-small Cell Lung Cancer NCI-H1299 Cells]

Identification and characterization of SP cells in human lung adenocarcinoma SPC-A1 cells

A high-throughput screen identifies inhibitors of lung cancer stem cells

[Isolation and in Vivo Tumorigenicity Assay of CD133+ Side Population Cells from Laryngeal Cancer Cell Line].

Cell-Based Selection Provides Novel Molecular Probes for Cancer Stem Cells

Isolation and identification of cancer stem cells in lung cancer cell lines as well as function analysis

Enrichment and Characterization of Cancer Stem Cells from A Human Non-Small Cell Lung Cancer Cell Line

Phenotypic analysis of common cancer stem cell markers and cell sorting in lung cancer cell line A549

Enrichment and Characterization of Cancer Stem-Like Cells in Ultra-Low Concentration of Serum and Non-Adhesive Culture System

CAN-09-4360 Cancer esearch or and Stem Cell Biology ge-Based Chemical Screening Identifies Drug Efflux R bitors in Lung Cancer Cells

Biologic characteristics of the side population of human small cell lung cancer cell line H446.